Cannabis induces a clinical response in patients with Crohn's disease: a prospective placebo-controlled study.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Clinical Gastroenterology and Hepatology

• Publication date

  2013-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.cgh.2013.04.034PMID 23648372
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Diagnostic and Statistical Manual of Mental Disorders

  2013cited by this paper
• Treatment of Crohn's disease with cannabis: an observational study.

  2011cited by this paper
• Immunoactive effects of cannabinoids: considerations for the therapeutic use of cannabinoid receptor agonists and antagonists.

  2010cited by this paper
• THEMED ISSUE: CANNABINOIDS RESEARCH PAPER The effects of D-tetrahydrocannabinol and cannabidiol alone and in combination on damage, inflammation and in vitro motility disturbances in rat colitisbph_791 712..723

  2010cited by this paper
• Activation of the cannabinoid 2 receptor (CB2) protects against experimental colitis

  2009cited by this paper
• Cannabidiol, a safe and non-psychotropic ingredient of the marijuana plant Cannabis sativa, is protective in a murine model of colitis

  2009cited by this paper
• Emerging role of cannabinoids in gastrointestinal and liver diseases: basic and clinical aspects

  2008cited by this paper
• Adverse effects of medical cannabinoids: a systematic review

  2008cited by this paper
• Diagnostic and Statistical Manual of Mental Disorders

  2008cited by this paper
• Human anti-tumor necrosis factor monoclonal antibody (adalimumab) in Crohn's disease: the CLASSIC-I trial.

  2006cited by this paper
• Anti-inflammatory potential of CB1-mediated cAMP elevation in mast cells.

  2005cited by this paper
• Modulation of the immune system in cannabis users.

  2003cited by this paper
• Cannabinoids in Clinical Practice

  2000cited by this paper
• Cannabinoid receptors and the regulation of immune response.

  2000cited by this paper
• Marginally improved detection of GM1 antibodies by Covalink ELISA in multifocal motor neuropathy

  1999cited by this paper
• How to randomise

  1999cited by this paper
• Medicinal marijuana: a comprehensive review.

  1998cited by this paper
• Adverse effects of cannabis.

  1998cited by this paper
• Diagnostic and Statistical Manual of Mental Disorders, 4th Ed.

  1994cited by this paper
• [Affective disorders in the fourth edition of the classification of mental disorders prepared by the American Psychiatric Association -- diagnostic and statistical manual of mental disorders].

  1993cited by this paper
• CLINICAL STUDIES OF CANNABIS TOLERANCE AND DEPENDENCE *

  1976cited by this paper
• [Decrease of cellular immunity in hashish (marihuana) smokers].

  1973cited by this paper
• The anti-edema activity of various naturally occurring cannabinoids.

  1973cited by this paper

• Combination of CBD with minor cannabinoid CBDV suppresses CXCR4 via CB2 receptor and alleviates colitis in mice.

  2025cites this paper
• The Endocannabinoid System: Implications in Gastrointestinal Physiology and Pathology

  2025cites this paper
• Cannabis use in Patients With Inflammatory Bowel Disease is Associated With Longer Endoscopic Duration and Endoscopic Inflammation

  2025cites this paper
• Quantum chemical and molecular modeling approaches for repurposing anticoagulants against SARS-CoV-2 main protease

  2025cites this paper
• Efficacy of non-psychotropic Cannabis sativa L. standardized extracts in a model of intestinal inflammation

  2025influential citation
• Efficacy of cannabis oil on appetite and quality of life in systemic sclerosis patients: a randomized placebo-controlled trial

  2025cites this paper
• Better together? Individual and synergistic effects of noneuphorigenic cannabinoids on visceral sensation.

  2025cites this paper
• Selected Use of Complementary and Alternative Medicine (CAM) Agents in IBD

  2025cites this paper
• Cannabidiol as an immune modulator: A comprehensive review

  2025cites this paper
• Cannabis use in Crohn’s disease: a systematic review and meta-analysis of randomized controlled trials (RCTs)

  2025cites this paper
• QSAR-driven discovery and ranking of potential anti-H1N1 inhibitors

  2025cites this paper
• Complementary medicines and ginseng for inflammatory bowel disease-rooted in science, but will it bear fruit?

  2025cites this paper
• Inflammatory bowel disease patients believe cannabis and cannabidiol oil relieve symptoms

  2025cites this paper
• The Cannabinoid System as a Potential Novel Target for Alcohol‐Associated Liver Disease: A Propensity‐Matched Cohort Study

  2025influential citation
• Rapid and robust quantification of ten cannabinoids in cannabis oils using FT-NIR spectroscopy coupled with PLS-R models.

  2025cites this paper
• O papel dos canabinóides na modulação da inflamação e da dor crônica

  2025cites this paper
• Cannabinoid CB2R regulates T cell gut-homing in preclinical Crohn’s model

  2025cites this paper
• Cannabis and Veterinary Medicine.

  2025cites this paper
• Is dependent cannabis use in adult hospitalizations with inflammatory bowel disease associated with major adverse cardiovascular and cerebrovascular events? Insights from National Inpatient Sample Analysis

  2024cites this paper
• Aktualisierte S3-Leitlinie „Diagnostik und Therapie des Morbus Crohn“ der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) (Version 4.1) – living guideline

  2024cites this paper
• The Potential of Cannabis in Managing Inflammatory Bowel Disease and Its Future Perspective

  2024cites this paper
• Medicinal Cannabis and the Intestinal Microbiome

  2024cites this paper
• Aquaphotomics study of fresh cannabis inflorescence: near infrared spectral analysis of water matrix structures

  2024cites this paper
• Meta-analysis of the Therapeutic Impact of Cannabinoids in Inflammatory Bowel Disease.

  2024cites this paper
• Comparative chemometric modeling of fresh and dry cannabis inflorescences using FT-NIR spectroscopy: Quantification and classification insights.

  2024cites this paper
• Cannabinoids for Inflammatory Bowel Disease: A Scoping Review

  2024influential citation
• The Perceived Effectiveness of Cannabidiol on Adult Women with Inflammatory Bowel Disease

  2024influential citation
• Association of Marijuana Use With Psychological Distress Among Adults in United States

  2024cites this paper
• High Cannabigerol Hemp Extract Moderates Colitis and Modulates the Microbiome in an Inflammatory Bowel Disease Model

  2024cites this paper
• Endogenous Cannabinoids in Crohn’s Disease

  2024cites this paper
• Legalization of Cannabis Does Not Reduce Opioid Prescribing in Patients With Inflammatory Bowel Disease: A Difference-in-Difference Analysis

  2024cites this paper
• Antioxidant and Anti-Inflammatory Phytochemicals for the Treatment of Inflammatory Bowel Disease: A Systematic Review

  2024cites this paper
• Effect of cannabinoids in mild-to-moderate cases of Crohn’s disease as compared to placebo: a systematic review and meta-analysis of randomised controlled trials

  2024cites this paper
• Effects of Cannabinoids on Intestinal Motility, Barrier Permeability, and Therapeutic Potential in Gastrointestinal Diseases

  2024cites this paper
• Cannabis sativa alleviates experimentally acetic acid- induced ulcerative colitis in rats: targeting CB1/SIRT/MAPK signaling pathways

  2024cites this paper
• Medicaid Analysis of Substances of Abuse for Patients With Crohn’s Disease

  2023cites this paper
• Should gastroenterologists prescribe cannabis? The highs, the lows and the unknowns

  2023cites this paper
• EXPLORANDO O POTENCIAL TERAPÊUTICO DOS CANABINOIDES EM DOENÇAS NEUROLÓGICAS

  2023cites this paper
• The Use of Cannabinoids in the Treatment of Inflammatory Bowel Disease (IBD): A Review of the Literature

  2023cites this paper
• Monitoring of patients with active inflammatory bowel disease

  2023cites this paper
• Cannabis products: medical use

  2023cites this paper
• Novel fluorescence spectroscopy coupled with PARAFAC modeling for major cannabinoids quantification and identification in cannabis extracts

  2023cites this paper
• Novel fluorescence spectroscopy method coupled with N-PLS-R and PLS-DA models for the quantification of cannabinoids and the classification of cannabis cultivars.

  2023cites this paper
• Chronic Cannabis Use is Associated with Altered Monocyte Phenotype, Immune Response, and Depression in Physically Active Individuals.

  2023cites this paper
• Exploration of Cannabis constituents as potential candidates against diabetes mellitus disease using molecular docking, dynamics simulations and ADMET investigations

  2023cites this paper
• Cannabinoids in Periodontology: Where Are We Now?

  2023cites this paper
• Pharmacohistory of Cannabis Use—A New Possibility in Future Drug Development for Gastrointestinal Diseases

  2023cites this paper
• Cannabinoids and the Endocannabinoid System in Early SARS-CoV-2 Infection and Long COVID-19—A Scoping Review

  2023cites this paper
• A Review of the Effects of Adolescent Cannabis Use on Physical Health.

  2023cites this paper
• Fatty acids and lipid mediators in inflammatory bowel disease: from mechanism to treatment

  2023cites this paper
• Cannabidiol - Help and hype in targeting mucosal diseases.

  2023cites this paper
• Abdominal Pain in Inflammatory Bowel Disease: An Evidence-Based, Multidisciplinary Review

  2023cites this paper
• Therapeutic Potential of Cannabis: A Comprehensive Review of Current and Future Applications

  2023cites this paper
• Patients’ perspectives on marijuana use for inflammatory bowel disease: a multicenter survey

  2023cites this paper
• Chronic abdominal pain in inflammatory bowel disease: a practical guide

  2023cites this paper
• Cannabinoids and the GI Tract.

  2023cites this paper
• Cannabinoids as Immune System Modulators: Cannabidiol Potential Therapeutic Approaches and Limitations

  2022cites this paper
• Holistic healthcare in inflammatory bowel disease: time for patient-centric approaches?

  2022cites this paper
• Cannabinoid Therapeutic Effects in Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

  2022cites this paper
• Long-term daily feeding of cannabidiol is well-tolerated by healthy dogs

  2022cites this paper
• Quantitative and qualitative spectroscopic parameters determination of major cannabinoids

  2022cites this paper
• Use of near-infrared spectroscopy for the classification of medicinal cannabis cultivars and the prediction of their cannabinoid and terpene contents.

  2022cites this paper
• Profiling the Use of Complementary Alternative Medicines among Inflammatory Bowel Disease Patients: Results from a Single Center Survey

  2022cites this paper
• Potential use of nanoencapsulated cannabinoids for the treatment of inflammatory bowel diseases: a systematic review

  2022cites this paper
• Medical Cannabis Use Patterns and Adverse Effects in Inflammatory Bowel Disease

  2022cites this paper
• Involvement of the cannabinoid system in chronic inflammatory intestinal diseases: opportunities for new therapies

  2022cites this paper
• Abdominal Pain in Inflammatory Bowel Diseases: A Clinical Challenge

  2022cites this paper
• Medical Students’ Attitudes, Knowledge, and Beliefs about Medical Cannabis: A Qualitative Descriptive Study

  2022cites this paper
• Lifestyle, behaviour, and environmental modification for the management of patients with inflammatory bowel diseases: an International Organization for Study of Inflammatory Bowel Diseases consensus.

  2022cites this paper
• Multivariate classification of cannabis chemovars based on their terpene and cannabinoid profiles.

  2022cites this paper
• Medical Cannabis Activity Against Inflammation: Active Compounds and Modes of Action

  2022cites this paper
• The Microbiome and Gut Endocannabinoid System in the Regulation of Stress Responses and Metabolism

  2022cites this paper
• Aktualisierte S3-Leitlinie „Diagnostik und Therapie des Morbus Crohn“ der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) – August 2021 – AWMF-Registernummer: 021-004

  2022cites this paper
• Therapeutic Potential of Cannabis, Cannabidiol, and Cannabinoid-Based Pharmaceuticals

  2022cites this paper
• A Review of the Effects of Adolescent Cannabis Use on Physical Health.

  2022cites this paper
• Exploring cannabis use and perspectives among psoriatic disease patients

  2022cites this paper
• Efficacy of cannabis and its constituents in disease management: Insights from clinical studies.

  2022cites this paper
• Cannabis and Its Potential Protective Role Against Inflammatory Bowel Disease: A Scoping Review

  2021influential citation
• Healthcare Maintenance in the Patient with Inflammatory Bowel Disease: High-Yield Interventions

  2021cites this paper
• [Cannabis use among patients with inflammatory bowel disease].

  2021cites this paper
• The effect of cannabis toxicity on a model microbiome bacterium epitomized by a panel of bioluminescent E. coli.

  2021cites this paper
• The Endocannabinoid System: A Potential Target for the Treatment of Various Diseases

  2021cites this paper
• Cannabis and Cannabis Derivatives for Abdominal Pain Management in Inflammatory Bowel Disease

  2021cites this paper
• Cannabisblüten bei Colitis ulcerosa

  2021cites this paper
• Emerging Comorbidities in Inflammatory Bowel Disease: Eating Disorders, Alcohol and Narcotics Misuse

  2021cites this paper
• Objective Identification of Cannabis Use Levels in Clinical Populations Is Critical for Detecting Pharmacological Outcomes

  2021cites this paper
• Modulatory role of the Endocannabinoidome in the pathophysiology of the gastrointestinal tract.

  2021cites this paper
• Cannabinoids and chronic pelvic pain in women: Focus on endometriosis

  2021cites this paper
• Cannabis and Inflammatory Bowel Disease: All Smoke and Mirrors?

  2021cites this paper
• Pharmacological properties, therapeutic potential, and legal status of Cannabis sativa L.: An overview

  2021cites this paper
• Cannabinoids and Inflammations of the Gut-Lung-Skin Barrier

  2021cites this paper
• Inflammatory Bowel Disease and Cannabis: A Practical Approach for Clinicians

  2021cites this paper
• Cannabis, a Miracle Drug with Polyvalent Therapeutic Utility: Preclinical and Clinical-Based Evidence

  2021cites this paper
• Therapeutic Attributes of Endocannabinoid System against Neuro-Inflammatory Autoimmune Disorders

  2021cites this paper
• Nutritional and Botanical Approaches for Inflammatory Bowel Disease

  2021cites this paper
• Cannabidiol Isolated From Cannabis sativa L. Protects Intestinal Barrier From In Vitro Inflammation and Oxidative Stress

  2021cites this paper
• Symptoms and Extraintestinal Manifestations in Active Cannabis Users with Inflammatory Bowel Disease

  2021cites this paper
• Relevance of monitoring transmural disease activity in patients with Crohn’s disease: current status and future perspectives

  2021cites this paper
• Cannabis and Autoimmunity: Possible Mechanisms of Action

  2021cites this paper
• Natural product–derived drugs for the treatment of inflammatory bowel diseases (IBD)

  2021cites this paper